Literature DB >> 28856089

Plexogenic pulmonary hypertension associated with POEMS syndrome.

Thomas Czeczok1, Peter Lin1, Eunhee Yi1.   

Abstract

Pulmonary hypertension is one of the well-known clinical manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome, occurring in approximately 25-30% of the affected individuals. However, the histopathologic spectrum of pulmonary hypertension associated with POEMS syndrome has not been fully documented in the literature. Herein, we report an autopsy case of POEMS syndrome in a patient whose lung tissues showed histopathology indistinguishable from that of idiopathic pulmonary arterial hypertension with abundant plexiform lesions in the small pulmonary arteries.

Entities:  

Keywords:  POEMS; Plexiform; Pulmonary hypertension

Year:  2017        PMID: 28856089      PMCID: PMC5565785          DOI: 10.1016/j.rmcr.2017.08.011

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare paraneoplastic syndrome associated with an underlying plasma cell disorder [1]. It is important to note that not all of the features within the acronym are required to make the diagnosis of POEMS syndrome. Also, there are other important features not included in the POEMS acronym, such as papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis/erythorocytosis, elevated vascular endothelial growth factor (VEGF) levels, a predisposition towards thrombosis, and abnormal pulmonary function test [1]. Pulmonary manifestations of POEMS syndrome are protean and include pulmonary hypertension (PH), which has been reported to occur in 27% of unselected patient with POEMS syndrome [2]. VEGF has been reported as the causative factor for PH in POEMS syndrome [3]. This study did not describe the histopathology of PH in their case, however. Since VEGF has been implicated in the formation of plexiform lesions, one can postulate that PH in POEMS syndrome might also have plexiform lesions, one of the most complex types of vascular remodeling invariably associated with severe PH seen in idiopathic and only certain secondary forms of PH [4]. Herein, we report an autopsy case of PH associated with POEMS syndrome showing plexogenic disease, which has not been well documented in the literature.

Report of a case

A 56-year-old woman presented with weight loss in December, 2014. Subsequent clinical evaluation revealed an elevated serum creatinine at 2.8 mg/dL (normal range 0.6–1.1). She underwent two renal biopsies in May and October of 2015, both of which were diagnosed as thrombotic microangiopathy. In December, 2015, a monoclonal gammopathy of IgG lambda was detected in her serum, and positron emission tomography (PET) scan revealed a lesion in the left sacrum. The left sacral biopsy was diagnosed as plasmacytoma, lambda light chain restricted, for which she received a radiation therapy during a period from February to March of 2016. Two weeks after completing radiation therapy, she developed painful skin ulcerations on thighs, abdomen, and breasts, accompanied by retinal hemorrhage, acute renal failure and shortness of breath. PET scan showed persistent sacral plasmacytoma. She also developed bilateral pleural effusions, which were drained. Postprocedural chest x-ray showed clear lung fields without evidence of pulmonary edema. Serum pro-beta-natriuretic peptide was markedly elevated (>60,000 pg/mL; normal <162 pg/mL). Transthoracic echocardiogram was obtained and was notable for a left ejection fraction of 26% and severe tricuspid valve regurgitation secondary to annular dilatation and incomplete coaptation of the valve leaflets. Mild to moderate mitral valve regurgitation was noted as well. There was mild biventricular enlargement, and moderate decrease in right ventricular systolic function. Estimated right ventricle pressure was 37 mmHg, which was thought to be underestimated. Right heart catheterization was not performed due to her clinical condition. The patient was evaluated by a multidisciplinary team including hematology, dermatology, ophthalmology, cardiology, nonvascular wound, nephrology, and palliative care. The consensus diagnosis of POEMS syndrome was made based on her clinical findings and also supported by the elevated serum VEGF level (697 pg/mL; normal range 31–86), elevated parathyroid hormone (315 pg/mL; normal range 15–65), elevated corticotropin, and multiple serum electrolyte abnormalities. She also had hypocalcemia in the setting of calciphylaxis with painful indurated ischemic plaques on the breast, abdomen, groin and thighs. She developed new onset of biventricular heart failure with severe tricuspid regurgitation. Given the poor prognosis, she was transitioned to comfort care and died in June 2016. Postmortem examination was limited to the chest and abdomen. At autopsy, the heart showed mild to moderate biventricular myocardial hypertrophy (heart 533 g, expected 248 g) with organizing fibrinous pericarditis. Hepatomegaly (2480 g; expected 1433 g) and splenomegaly (520 g; expected 143 g) were present with serous ascites (800 mL) in the abdomen. On microscopic examination of the lungs, the airways were unremarkable and the alveolar architecture was well preserved without significant interstitial fibrosis or inflammatory infiltrate. The small muscular pulmonary arteries showed multiple plexiform lesions (Fig. 1). Some small pulmonary arteries contained organizing thrombus. There was no significant alveolar hemosiderosis or pulmonary venous/venular occlusion on hematoxylin and eosin and Verhoeff-Van Giesen stainings. No significant alveolar capillary engorgement or pulmonary capillary hemangiomatosis-like reaction was noted.
Fig. 1

Hematoxalin and eosin stains of plexiform lesions and recanalizing thrombi (A and B, respectively). Verhoeff–Van Gieson stain highlights these lesions (C and D).

Hematoxalin and eosin stains of plexiform lesions and recanalizing thrombi (A and B, respectively). Verhoeff–Van Gieson stain highlights these lesions (C and D). The overall pulmonary vascular findings were consistent with pre-capillary hypertensive pulmonary vascular disease of plexogenic type, occurring in a background of otherwise unremarkable lung tissue, except for superimposed acute pneumonia in the lower lobes. Of note, there was zone 3 congestion and hepatocyte necrosis in the liver, in keeping with the presence of severe PH. No evidence of plasmacytoma was identified either in the lung or any other organ.

Discussion

We report a case of PH in a patient who had characteristic clinical and laboratory features of POEMS syndrome. Postmortem examination of the lung showed many plexiform lesions, indicative of the plexogenic form of pulmonary arterial hypertension. It is of note that plexogenic disease has the same histopathologic appearance regardless of whether it is of idiopathic or secondary type. Although the patient also had a left heart failure, no features of secondary pulmonary venous hypertension were found on the lung sections. The precise mechanism of development for plexiform lesion is not fully understood. Plexiform lesions are best known in idiopathic pulmonary arterial hypertension (formerly primary pulmonary hypertension) but can be seen in several types of secondary PH such as congenital heart disease with high volume left to right shunt, human immunodeficiency virus infection, liver disease and some collagen vascular diseases. POEMS syndrome is a rare disease characterized by mandatory, major, and minor criteria (Table 1). The diagnosis is made when both mandatory, one major, and one minor criteria are met. Individuals with POEMS syndrome are at risk of developing PH, with a prevalence of 27–36% [1], [2]. Those who have PH have poorer overall survival, with a median survival of 54 months in one study and hazard ratio of 3.99 in another [1], [5]. Development of pleural effusion is also deleterious [5]. PH improved with treatment of the underlying plasma cell disorder in 88% of individuals undergoing either medical therapy including melphalan and steroids or autologous transplant [1], [6]. Melphalan based treatment is superior to steroids alone. Improved pulmonary function and right ventricular pressure after radiation treatment for plasmacytoma has been reported [7].
Table 1

Diagnostic criteria for POEMS syndrome.

Mandatory major criteria

Polyneuropathy

Monoclonal plasma cell-proliferative disorder

Other major criteria

Castleman disease

Sclerotic bone lesions

VEGF elevation

Minor criteria

Organomegaly (splenomegaly, hepatomegaly, or lymphadenopathy)

Extravascular volume overload (edema, pleural effusion, or ascites)

Endocrinopathy (adrenal, thyroid, pituitary, gonadal, parathyroid, and pancreatic)

Skin changes (hyperpigmentation,hypertrichosis, glomeruloid hemangiomata,plethora, acrocyanosis, flushing)

Papilledema

Thrombocytosis/polycythemia

Other symptoms and signs

Weight loss, hyperhidrosis, pulmonary hypertension, thrombotic

diathesis, diarrhea

Diagnostic criteria for POEMS syndrome. Polyneuropathy Monoclonal plasma cell-proliferative disorder Castleman disease Sclerotic bone lesions VEGF elevation Organomegaly (splenomegaly, hepatomegaly, or lymphadenopathy) Extravascular volume overload (edema, pleural effusion, or ascites) Endocrinopathy (adrenal, thyroid, pituitary, gonadal, parathyroid, and pancreatic) Skin changes (hyperpigmentation,hypertrichosis, glomeruloid hemangiomata,plethora, acrocyanosis, flushing) Papilledema Thrombocytosis/polycythemia Weight loss, hyperhidrosis, pulmonary hypertension, thrombotic diathesis, diarrhea Elevated serum VEGF is common in POEMS syndrome. VEGF increases microvascular permeability leading to volume overload, stimulates endothelial proliferation, induces endothelial dysfunction and activates vascular smooth muscle [8], [9], [10], [11]. VEGF is strongly expressed in plexiform lesions in primary and secondary PH [12], [13], [14]. VEGF also plays a role in the development of renal thrombotic microangiopathy, a form of vascular remodeling, which was found on the premortem renal biopsies as well as on the postmortem examination of the kidney tissues. To our knowledge, a single case report describes pulmonary findings in an autopsy performed on a 49-year-old woman who died of complications of pulmonary hypertension in the setting of POEMS syndrome [15]. A prominent plasmacytic infiltrate was present within vessels causing stenosis, and in some vessels recanalization. No plexogenic arteriopathy, or thrombi were noted in contrast to this case.

Conclusion

In summary, we documented the presence of well-developed plexiform lesions in PH associated with POEMS syndrome that has not been well illustrated in the literature to our knowledge. Elevated VEGF level might be related with the development of plexiform lesions in POEMS syndrome.
  15 in total

1.  VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome.

Authors:  H Niimi; K Arimura; M Jonosono; T Hashiguchi; M Kawabata; M Osame; I Kitajima
Journal:  Intern Med       Date:  2000-12       Impact factor: 1.271

2.  Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome.

Authors:  Satish Chandrashekaran; Angela Dispenzieri; Stephen S Cha; Cassie C Kennedy
Journal:  Respir Med       Date:  2014-11-14       Impact factor: 3.415

Review 3.  Vascular endothelial growth factor in the lung.

Authors:  Norbert F Voelkel; R William Vandivier; Rubin M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-02       Impact factor: 5.464

4.  Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.

Authors:  R M Tuder; M Chacon; L Alger; J Wang; L Taraseviciene-Stewart; Y Kasahara; C D Cool; A E Bishop; M Geraci; G L Semenza; M Yacoub; J M Polak; N F Voelkel
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

5.  Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome.

Authors:  M Soubrier; C Sauron; B Souweine; C Larroche; B Wechsler; L Guillevin; J C Piette; H Rousset; P Deteix
Journal:  Am J Kidney Dis       Date:  1999-10       Impact factor: 8.860

6.  Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.

Authors:  O Watanabe; I Maruyama; K Arimura; I Kitajima; H Arimura; M Hanatani; K Matsuo; T Arisato; M Osame
Journal:  Muscle Nerve       Date:  1998-11       Impact factor: 3.217

7.  Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome.

Authors:  C Wang; X-F Huang; Q-Q Cai; X-X Cao; M-H Duan; H Cai; D-B Zhou; J Li
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

8.  Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome.

Authors:  O Watanabe; K Arimura; I Kitajima; M Osame; I Maruyama
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

Review 9.  POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.

Authors:  Angela Dispenzieri
Journal:  Am J Hematol       Date:  2014-02       Impact factor: 10.047

10.  Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.

Authors:  Marina Scarlato; Stefano Carlo Previtali; Marinella Carpo; Davide Pareyson; Chiara Briani; Roberto Del Bo; Eduardo Nobile-Orazio; Angelo Quattrini; Giacomo Pietro Comi
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

View more
  2 in total

1.  Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors:  Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2019-11-20       Impact factor: 3.017

2.  Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome.

Authors:  Kana Ohashi; Rintaro Nishimura; Shunsuke Sugimoto; Seiichiro Sakao; Nobuhiro Tanabe; Koichiro Tatsumi
Journal:  Respirol Case Rep       Date:  2019-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.